- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
A GP challenged a Takeda promotional leavepiece for pioglitazone that presented benefits as relative risk reduction but harms as absolute risk. The…
Anonymous complaint alleged Trinity-Chiesi sponsored a switch service to Clenil. Panel reviewed the Clinical Support Service documents and process and found no…
A pharmacist challenged an Actonel leavepiece citing NICE July 2008. The Panel found the title and quotations misleading, including an unbalanced risedronate…
A rheumatologist complained that an RCP webcast sponsored by Roche effectively promoted rituximab. The Panel found Roche’s sponsorship was transparent and arm’s…
Servier’s letter, press release and symposium materials implied acid suppressants increased fracture risk and reduced bisphosphonate efficacy. The Panel and Appeal Board…
A GP challenged a Prescriber journal ad for Micardis/Micardis Plus. The Panel found the headline implied long-term cardiovascular benefit inconsistent with the…
Novo Nordisk-funded Times supplement included interview claims about liraglutide trial benefits before approval. Panel found public promotion, lack of due diligence and…
A pharmacist alleged a Crestor journal ad implied NICE cholesterol targets had been reduced and omitted first-line NICE advice. The Panel found…
Bayer Schering was found to have promoted Xarelto (rivaroxaban) before UK marketing authorisation via a UK exhibition stand and a journal insert,…
A member of the public saw Triumeq promotional material on a train on a third-party employee’s iPad. Panel found no promotion to…
GSK admitted a travel health pricing proposal sent to buying groups became promotional due to “Excellent Products”. It lacked PI, INNs and…
An internal email implied AUA meeting sponsorship was tied to protecting/growing Zoladex prescriptions. One rep forwarded it to a doctor. PMCPA ruled…
A hospital doctor alleged a Lundbeck rep made a joint visit with a competitor rep and discussed rival products. The complainant was…
A rheumatoid arthritis supplement funded by Roche/Chugai was stapled into the Health Service Journal. On appeal, the PMCPA ruled the inside pages…
Anonymous key account manager alleged verbal contact-rate targets forced Code breaches. Panel found no evidence targets required excessive calls; company data suggested…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.